TARS – tarsus pharmaceuticals, inc. (US:NASDAQ)

News

Tarsus Pharmaceuticals: Marketing Spend Bears Fruit, Pipeline Progresses [Seeking Alpha]
Tarsus Pharmaceuticals (TARS) was upgraded by Wall Street Zen from "h
How TP-05's Phase 2 Lyme Prophylaxis Trial Progress Could Impact Tarsus Pharmaceuticals (TARS) Investors [Yahoo! Finance]
Tarsus Doses First Participant in Calliope, A Phase 2 Clinical Trial of TP-05 (lotilaner), a Novel Investigational Oral Tablet for the Potential Prevention of Lyme Disease
Tarsus Pharma Stock Up 20% as Insider Sells $839K in RSU-Linked Trade [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com